<DOC>
	<DOCNO>NCT02434770</DOCNO>
	<brief_summary>The purpose study evaluate whether bivalent oral polio vaccine ( bOPV ) manufacture Beijing TiantanBio similar immunogenicity profile WHO pre-qualified bOPV .</brief_summary>
	<brief_title>Immunogenicity Safety Liquid Bivalent Oral Poliomyelitis Vaccine</brief_title>
	<detailed_description>Beijing TiantanBio one two supplier tOPV China since 1985 , control polio China evidence effectiveness vaccine . The company plan introduce liquid formulation bOPV ( type 1 3 ) meet increase global demand phasing-out tOPV . The propose study intend provide data sufficient obtain WHO prequalification TiantanBio bOPV , thus make vaccine available help meet global demand .</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy , fullterm infant , establish medical history clinical examination enter study . Parents willing provide write informed consent . Age : infant le 2 week age time enrollment ( 1st 14th day life , inclusive ) Birth weight ( document first medical contact ) less 2.5 kg Presence diarrhea vomit previous 24 hour day enrolment ( temporary exclusion ) Presence fever ( &gt; 37.5oC ) day enrollment ( temporary exclusion ) Acute disease time enrollment ( temporary exclusion ) Significant malnutrition per Investigator 's judgment Concurrent participation another clinical study time study period infant expose investigational noninvestigational product Presence significant systemic disorder ( cardiovascular , pulmonary , hepatic , renal , gastrointestinal , hematological , endocrine , immunological , dermatological , neurological , cancer autoimmune disease ) determine medical history and/or physical examination would compromise child 's health likely result nonconformance protocol Known suspect impairment immunological function ( include HIV exposure ) base medical history physical examination Previous receipt poliovirus vaccine Household contact know immunosuppressed individual Unwillingness inability parent active followup study staff History neurologic disorder seizures Any medical condition , judgment investigator , would interfere serve contraindication protocol adherence participant 's ability give inform consent Maternal HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>